Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study
Identificadores
Identificadores
URI: http://hdl.handle.net/20.500.11940/2415
PMID: 23799855
DOI: 10.1038/bjc.2013.272
ISSN: 0007-0920
Servizos
Servizos
Data de publicación
2013Título da revista
BRITISH JOURNAL OF CANCER
Tipo de contido
Artigo
